Celldex Therapeutics - 33 Year Stock Price History | CLDX

Historical daily share price chart and data for Celldex Therapeutics since 1990 adjusted for splits. The latest closing stock price for Celldex Therapeutics as of January 31, 2023 is 44.06.
  • The all-time high Celldex Therapeutics stock closing price was 3015.00 on March 06, 2000.
  • The Celldex Therapeutics 52-week high stock price is 48.40, which is 9.9% above the current share price.
  • The Celldex Therapeutics 52-week low stock price is 19.85, which is 54.9% below the current share price.
  • The average Celldex Therapeutics stock price for the last 52 weeks is 32.93.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Celldex Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 45.6110 43.3900 47.4300 42.7700 44.0600 -1.14%
2022 31.8473 39.1800 45.3800 20.5000 44.5700 15.35%
2021 35.4060 19.1000 56.2700 16.1900 38.6400 120.55%
2020 9.1735 2.2500 22.7500 1.5500 17.5200 685.65%
2019 3.2993 3.7590 10.3605 2.0500 2.2300 -24.88%
2018 15.8147 43.8000 46.0500 2.9250 2.9685 -93.03%
2017 44.1236 54.1500 59.4000 33.6000 42.6000 -19.77%
2016 73.3952 224.8499 232.0499 43.0500 53.1000 -77.42%
2015 313.1284 276.1499 476.6998 155.6999 235.1999 -14.08%
2014 267.6088 369.1498 473.8498 166.3499 273.7499 -24.62%
2013 267.0740 104.9999 567.4497 104.6999 363.1498 260.80%
2012 75.2200 41.7000 103.9499 41.5500 100.6499 158.08%
2011 49.8277 63.3000 66.9000 31.6500 39.0000 -36.89%
2010 76.6900 70.6500 141.4499 51.3000 61.8000 -11.78%
2009 101.9684 119.8499 172.4999 63.0000 70.0500 -41.04%
2008 155.3311 100.7999 269.6999 67.9500 118.7999 32.00%
2007 161.1896 246.5999 278.9999 73.8000 90.0000 -62.69%
2006 299.3162 338.3998 457.1998 228.5999 241.1999 -28.72%
2005 271.9856 368.9998 390.5998 208.7999 338.3998 -6.47%
2004 420.2498 496.7998 678.5997 282.5999 361.7998 -26.64%
2003 357.5355 210.5999 554.3997 174.5999 493.1998 142.48%
2002 271.5141 707.3996 721.7996 129.5999 203.3999 -71.82%
2001 845.9778 1159.1994 1519.1992 404.9998 721.7996 -41.63%
2000 1471.5350 415.7998 3014.9985 370.7998 1236.5994 178.14%
1999 331.9641 349.1998 561.5997 201.5999 444.5998 41.14%
1998 391.3212 404.9998 809.9996 190.7999 314.9998 -28.28%
1997 333.6473 291.5999 568.7997 230.3999 439.1998 50.62%
1996 484.5612 584.9997 786.5996 286.1999 291.5999 -48.08%
1995 650.6640 449.9998 966.5995 426.5998 561.5997 24.80%
1994 721.9854 1529.9992 1529.9992 381.5998 449.9998 -67.74%
1993 1211.4065 1304.9993 1461.5993 854.9996 1394.9993 5.16%
1992 1461.6630 2226.5989 2519.9987 1056.5995 1326.5993 -33.00%
1991 1256.1717 516.5997 2474.9988 516.5997 1979.9990 274.15%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.080B $0.005B
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $153.147B 9.34
GSK (GSK) United Kingdom $71.894B 8.95
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.086B 18.92
Ginkgo Bioworks Holdings (DNA) United States $3.531B 0.00
Myovant Sciences (MYOV) United Kingdom $2.613B 0.00
Arcus Biosciences (RCUS) United States $1.618B 24.29
Biohaven (BHVN) United States $1.266B 0.00
Emergent Biosolutions (EBS) United States $0.645B 5.07
ADC Therapeutics SA (ADCT) Switzerland $0.378B 0.00
Ambrx Biopharma (AMAM) United States $0.078B 0.00
Enzo Biochem (ENZ) United States $0.067B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.022B 0.00